Results 161 to 170 of about 4,073,186 (254)
Executive Summary of the ASN Kidney Health Guidance on the Cardiovascular‑Kidney‑Metabolic Syndrome. [PDF]
Navaneethan SD +3 more
europepmc +1 more source
Chronic kidney disease‐associated pruritus (CKDaP) is a frequent complication of advanced CKD with an incompletely understood pathophysiology. We identified a significantly altered glycine‐to‐taurine conjugated bile acid ratio in patients with CKDaP despite unchanged total serum bile acid concentrations.
Miriam M. Düll +6 more
wiley +1 more source
ASN Kidney Health Guidance on the Cardiovascular-Kidney-Metabolic Syndrome. [PDF]
Bansal N +13 more
europepmc +1 more source
ABSTRACT Background Stevens−Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe mucocutaneous reactions associated with significant morbidity and mortality. Published studies have identified a limited number of variables predictive of death, but their description of acute complications is sparse.
Damilola Oladinni +2 more
wiley +1 more source
Associations of Cardiovascular-Kidney-Metabolic Syndrome With All-Cause and Cardiovascular Death and the Progression of Cardiovascular-Kidney-Metabolic Syndrome Among Hong Kong Chinese People Over 2 Decades. [PDF]
Li L +13 more
europepmc +1 more source
ABSTRACT Metabolic dysfunction‐associated steatotic liver disease (MASLD) and obstructive sleep apnea (OSA) are comorbid conditions that synergistically increase cardiovascular risk through systemic inflammation and insulin resistance. While continuous positive airway pressure (CPAP) is the standard treatment for OSA, its efficacy in improving hepatic ...
Hsiao‐Chin Shen +10 more
wiley +1 more source
Butyrate and Butyrate-Producing Bacteria in Cardiovascular-Kidney-Metabolic Syndrome. [PDF]
Huang W +5 more
europepmc +1 more source
ABSTRACT The cardiovascular–kidney–metabolic (CKM) framework and metabolic dysfunction–associated steatotic liver disease (MASLD) describe a shared clinical continuum, but the prognostic value of joint fatty liver index (FLI)–NAFLD fibrosis score (NFS) phenotypes across CKM stages is uncertain.
Yi‐Fei Wang +5 more
wiley +1 more source
Cardiovascular-Kidney-Metabolic Syndrome and Health Risk Behaviors in U.S. Adults. [PDF]
Sharma M +5 more
europepmc +1 more source
Proteoforms in Disease: Biomedical Applications of Top‐Down Proteomics
ABSTRACT The proteome is a dynamic landscape of proteoforms arising from genetic mutations, alternative splicing, and post‐translational modifications (PTMs), which collectively drive biological function and disease phenotypes. Mass spectrometry (MS)‐based proteomics has emerged as an essential technique for elucidating this molecular complexity ...
Holden T. Rogers +5 more
wiley +1 more source

